A detailed history of Exeter Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Exeter Financial, LLC holds 19,642 shares of ABBV stock, worth $3.54 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares
19,642
Previous 20,829 5.7%
Holding current value
$3.54 Million
Previous $3.57 Million 8.57%
% of portfolio
1.75%
Previous 1.73%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $194,478 - $236,604
-1,187 Reduced 5.7%
19,642 $3.88 Million
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $148,443 - $173,348
-959 Reduced 4.4%
20,829 $3.57 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $31,644 - $36,055
-198 Reduced 0.9%
21,788 $3.97 Million
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $37,289 - $41,996
271 Added 1.25%
21,986 $3.41 Million
Q3 2023

Oct 16, 2023

BUY
$133.59 - $154.65 $82,425 - $95,419
617 Added 2.92%
21,715 $3.24 Million
Q2 2023

Jul 27, 2023

BUY
$132.51 - $164.9 $64,002 - $79,646
483 Added 2.34%
21,098 $2.84 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $48,010 - $55,291
-332 Reduced 1.58%
20,615 $3.29 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $9,543 - $11,445
-69 Reduced 0.33%
20,947 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $86,297 - $98,976
643 Added 3.16%
21,016 $2.82 Million
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $15,551 - $19,770
-113 Reduced 0.55%
20,373 $3.12 Million
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $171,574 - $212,875
-1,300 Reduced 5.97%
20,486 $3.32 Million
Q4 2021

Jan 25, 2022

SELL
$107.43 - $135.93 $32,229 - $40,779
-300 Reduced 1.36%
21,786 $2.97 Million
Q3 2021

Oct 22, 2021

BUY
$106.4 - $120.78 $10,640 - $12,078
100 Added 0.45%
22,086 $2.38 Million
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $71,610 - $78,834
700 Added 3.29%
21,986 $2.38 Million
Q4 2020

Feb 05, 2021

SELL
$80.49 - $108.67 $4,024 - $5,433
-50 Reduced 0.23%
21,286 $2.28 Million
Q2 2020

Jul 21, 2020

SELL
$73.37 - $98.18 $64,345 - $86,103
-877 Reduced 3.95%
21,336 $2.1 Million
Q1 2020

Apr 23, 2020

BUY
$64.5 - $97.79 $74,175 - $112,458
1,150 Added 5.46%
22,213 $1.69 Million
Q4 2019

Jan 29, 2020

SELL
$72.13 - $90.25 $22,288 - $27,887
-309 Reduced 1.45%
21,063 $1.87 Million
Q2 2019

Jul 26, 2019

BUY
$65.7 - $83.98 $36,135 - $46,189
550 Added 2.64%
21,372 $1.55 Million
Q1 2019

Apr 09, 2019

SELL
$77.14 - $90.79 $42,812 - $50,388
-555 Reduced 2.6%
20,822 $1.68 Million
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $15,569 - $19,202
200 Added 0.94%
21,377 $1.97 Million
Q2 2018

Sep 24, 2018

BUY
$89.78 - $106.23 $26,934 - $31,869
300 Added 1.44%
21,177 $1.96 Million
Q1 2018

Sep 24, 2018

SELL
$92.01 - $123.21 $151,816 - $203,296
-1,650 Reduced 7.32%
20,877 $1.98 Million
Q4 2017

Sep 24, 2018

BUY
$89.56 - $98.21 $2.02 Million - $2.21 Million
22,527
22,527 $2.18 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Exeter Financial, LLC Portfolio

Follow Exeter Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exeter Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exeter Financial, LLC with notifications on news.